Ambarella (AMBA) Q2 2027 earnings review
Edge AI Momentum Accelerates, But Margins Linger at Trough
Ambarella delivered a solid top-line beat in Q2, with revenue growing 13.2% YoY to $108.1 million, fueled by strong demand for its 5nm AI SoCs in both Auto and IoT end markets. Management is aggressively pivoting its go-to-market engine, signing 7-year strategic agreements with global distributor Macnica and systems integrator Capgemini. However, the top-line success is masking profitability friction: non-GAAP gross margin compressed to 59.3% (down from 60.5% a year ago), lingering at the bottom of the company's 59-62% long-term target model. Q3 guidance implies a robust sequential revenue acceleration, but margin expansion remains conspicuously absent.
🐂 Bull Case
The long-promised shift to an indirect sales model is executing. 7-year agreements with Macnica and Capgemini will dramatically scale Ambarella's reach into highly fragmented but lucrative robotics and edge infrastructure markets without massive OpEx bloat.
The CV75 and CV72 AI SoCs are ramping aggressively, driving balanced sequential growth across both Auto and IoT. This validates Ambarella's multi-year R&D pivot toward complex Edge AI workloads.
🐻 Bear Case
Management has repeatedly touted that 5nm chips command 'premium ASPs'. Yet, corporate gross margins are down 120 bps YoY. Either high-volume, lower-margin consumer deals are dragging the average, or component inflation (like DRAM) is eating the ASP uplift.
Cash and marketable securities declined again to $272.3M. Following Q1's massive strategic inventory build (which spiked to 145 days), investors need clarity on whether this working capital is successfully converting to cash or sitting idle.
⚖️ Verdict: ⚪
Neutral. The commercial traction of the Edge AI portfolio and the launch of the standalone X7 accelerator are excellent leading indicators for top-line growth. However, until the margin deterioration reverses, earnings leverage will remain muted.
Key Themes
Go-to-Market Overhaul Achieving Scale
For the past year, Ambarella teased building an indirect sales channel (ISVs, SIs) to target the 'long tail' of robotics and physical AI. Q2 brought the receipts: 7-year agreements with Macnica (a massive technical distributor) and Capgemini (global engineering). This is a critical structural shift that transitions Ambarella from a direct-sales component vendor to an ecosystem platform, effectively multiplying its salesforce without the associated OpEx.
Advanced Node (5nm) Ramp Yielding Results
The CV75 and CV72 5nm AI SoCs are cited as the primary drivers of Q2's 'very strong growth.' These chips target increasingly complex workloads (GenAI, Vision-Language Action models) at the edge, successfully pushing Ambarella up the value chain away from legacy, commoditized vision processing.
Gross Margin Structurally Compressed
Non-GAAP gross margin landed at 59.3%, down from 60.5% in 26Q2 and 60.9% in 26Q3. This directly contradicts the bullish narrative that higher-priced 5nm chips will structurally elevate profitability. It implies that Ambarella is likely conceding margin to win high-volume deals, or that supply chain friction (such as the memory cost inflation flagged in prior quarters) is actively neutralizing pricing power.
Serviceable Market (SAM) Expansion
Driven by the new Capgemini/Macnica partnerships and the introduction of standalone AI accelerators, CEO Fermi Wang noted an increase in the company's 5-year SAM forecast for edge and Physical AI. The company is actively moving out of the narrow 'camera' pigeonhole and into broader industrial and enterprise AI compute.
One-Time R&D Accounting Noise
GAAP operating expenses benefited from a bizarre $9.0 million reduction in R&D expense due to the 'release of a deposit liability following the termination of a development project.' Management rightfully excluded this from non-GAAP results, but it artificially shrunk the headline GAAP net loss for the quarter.
Other KPIs
Up 28% YoY from $6.4 million in 26Q2. Despite the 120 bps drag on gross margins, the company is extracting operating leverage. Non-GAAP EPS of $0.18 handily beat the prior year's $0.15, signaling that rigorous OpEx control is allowing the top-line recovery to fall through to the bottom line.
Declined from $277.8 million at the end of Q1, and down from $295.3 million in Q3 of last year. While the balance sheet remains fortress-like with no structural debt risk, the steady cash burn over recent quarters highlights the working capital intensity of ramping new 5nm product nodes and strategic inventory builds.
Guidance
Accelerating. The $119.5 million midpoint implies a robust 10.5% sequential growth over Q2, and roughly 10% YoY growth against a tough comp (Q3 FY26 was an all-time record quarter at $108.5M). This proves the Q2 momentum was not a blip and edge AI demand is sustaining.
Stable to slightly Decelerating. The midpoint of 59.5% essentially flatlines compared to Q2's 59.3%, but remains materially lower than the 60.9% achieved in the same quarter last year. It sits uncomfortably at the absolute floor of management's long-term 59-62% target.
Stable. The midpoint of $58.0 million is highly consistent with historical run-rates, illustrating disciplined cost controls even as the company scales top-line revenue into record territory.
Key Questions
The Gross Margin Disconnect
If the 5nm CV72/CV75 SoCs command premium ASPs and are driving 'very strong growth,' why is corporate gross margin hovering at the bottom edge of the 59-62% target model? Is this driven by high-volume consumer IoT mix, or supply chain component inflation?
X7 Accelerator Positioning
The introduction of the X7 standalone AI accelerator is a major pivot from integrated SoCs. How does this change the competitive landscape? Are you targeting edge data center workloads, or acting as a co-processor in existing legacy IoT endpoints?
Inventory Conversion Status
Last quarter featured a massive strategic inventory build to 145 days. Did Q2 revenue growth successfully burn through this buffer, or is cash still heavily tied up in working capital?
Canceled Development Project
Can you provide more color on the $9 million development project termination? Was this a custom ASIC engagement that fell through, or the cancellation of an internal R&D node?